Storage Serum (3) & Plasma (3) at Chughtai Lab

Understanding Storage Serum (3) & Plasma (3) at Chughtai Lab

Storage Serum (3) & Plasma (3) is a highly specialized laboratory service offered by Chughtai Lab, Pakistan's premier diagnostic network. This service is designed for the systematic collection, processing, division, and long-term preservation of a patient's blood components. Specifically, it involves separating the blood into its two primary liquid components—serum and plasma—and dividing each into three distinct aliquots (a total of six vials). These aliquots are then preserved under ultra-low temperature conditions (typically at -80°C) to maintain molecular, enzymatic, and cellular stability for future diagnostic, therapeutic, or research applications.

To appreciate the clinical value of this service, it is essential to understand the physiological difference between serum and plasma. Serum is the liquid portion of the blood that remains after natural coagulation has occurred. It contains electrolytes, hormones, antibodies, antigens, and exogenous substances, but lacks clotting factors such as fibrinogen. Plasma, on the other hand, is obtained by treating whole blood with anticoagulants (such as EDTA, heparin, or sodium citrate) and centrifuging it. Plasma retains all clotting factors and proteins. By storing three aliquots of each, healthcare providers and researchers ensure they have sufficient, high-quality specimens to perform multiple assays over time without subjecting the samples to repeated, destructive freeze-thaw cycles.

The preservation of these samples at Chughtai Lab utilizes state-of-the-art biobanking technology. This includes ultra-low temperature freezers, continuous automated temperature monitoring systems, and advanced Laboratory Information Management Systems (LIMS) for precise barcoding and sample tracking. This service is invaluable for patients undergoing longitudinal monitoring for complex diseases, individuals participating in clinical trials, and physicians requiring baseline comparative data for progressive medical conditions.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is critical to ensure the long-term stability and diagnostic utility of the stored serum and plasma samples. Patients must strictly adhere to the following guidelines prior to sample collection:

• Fasting Requirements: Patients are generally required to fast for 8 to 12 hours before the blood draw. Fasting prevents lipemia (an excess of lipids in the blood), which can cause turbidity in the serum and plasma, potentially interfering with future optical and chemical assays.
• Hydration: Drinking plenty of water is highly recommended. Adequate hydration ensures optimal blood volume, makes venipuncture easier, and prevents hemoconcentration, which can artificially elevate certain analyte levels.
• Medication Management: Patients should consult their referring physician regarding their routine medications. Certain drugs can alter biochemical markers; however, medications should never be discontinued without direct medical supervision.
• Avoidance of Alcohol and Vigorous Exercise: Patients must avoid alcohol consumption and strenuous physical activity for at least 24 hours prior to the test, as these can alter liver enzymes, metabolic markers, and fluid balance.

During the Procedure

The sample collection and processing workflow at Chughtai Lab follows strict international protocols to prevent contamination and sample degradation:

• Venipuncture: A certified phlebotomist performs a standard venipuncture, typically accessing the median cubital vein in the antecubital fossa. Using a sterile, closed vacuum system, the phlebotomist draws blood into specific collection tubes: Serum Separator Tubes (SST) or plain tubes for serum, and anticoagulant-treated tubes (such as EDTA or Sodium Citrate) for plasma.
• Initial Processing: The collected blood tubes are allowed to stand. The serum tubes must clot completely at room temperature for 30 to 45 minutes, while the plasma tubes are immediately but gently inverted to mix with the anticoagulant.
• Centrifugation: Both sets of tubes are placed in a temperature-controlled centrifuge. Centrifugation is carried out at precise speeds (typically 3000 RPM for 15 minutes) to cleanly separate the cellular elements from the liquid supernatant.
• Aliquoting: Under a sterile laminar flow hood to prevent environmental contamination, a laboratory technologist carefully pipettes the supernatant. The serum is divided equally into three cryovials, and the plasma is divided into another three cryovials. Each vial is labeled with a unique, high-density barcode linked to the patient's electronic medical record.
• Cryopreservation: The six labeled cryovials are immediately transferred to an ultra-low temperature freezer maintained at -80°C. This rapid freezing process preserves the structural integrity of proteins, nucleic acids, and other biomarkers, halting enzymatic degradation.

When is a Storage Serum (3) & Plasma (3) Performed?

Participation in Clinical Trials and Investigative Research

Pharmaceutical and clinical research protocols frequently require the collection of baseline biological samples before a therapeutic intervention begins. Storing three aliquots of both serum and plasma allows researchers to perform retrospective analyses as new biomarkers are discovered or as the trial progresses. The multiple aliquots ensure that testing can be repeated or validated in different reference laboratories without compromising the primary sample through repeated freeze-thaw cycles.

Longitudinal Monitoring of Oncology Patients

In oncology, tumor markers and circulating cell-free DNA (cfDNA) can fluctuate based on treatment efficacy, disease remission, or recurrence. Oncologists frequently request sample storage at specific clinical milestones. Having preserved serum and plasma from pre-treatment, mid-treatment, and post-treatment phases allows for direct, side-by-side comparative testing using the same laboratory assays, eliminating inter-assay variability and providing a clear picture of disease trajectory.

Management of Complex Autoimmune and Inflammatory Diseases

Autoimmune disorders such as systemic lupus erythematosus (SLE) or rheumatoid arthritis are characterized by flare-ups and periods of quiescence. Storing serum and plasma during active disease phases allows rheumatologists to preserve high concentrations of autoantibodies, cytokines, and inflammatory mediators. These stored samples can later be analyzed alongside samples collected during remission to evaluate the molecular response to immunosuppressive therapies.

Serial Therapeutic Drug Monitoring (TDM)

For patients on complex, narrow-therapeutic-index medications or novel biologic therapies, drug levels and anti-drug antibody titers must be carefully monitored. Storing multiple aliquots of serum and plasma allows clinical pharmacologists to evaluate drug clearance, steady-state concentrations, and the development of immunogenicity over an extended treatment timeline, ensuring personalized and safe dosing regimens.

Preservation of Rare Diagnostic Specimens

When patients present with highly unusual clinical symptoms suggestive of rare metabolic, infectious, or genetic conditions, immediate definitive testing may not be locally available. Storing three aliquots of serum and plasma preserves these precious specimens while logistics are arranged for specialized international reference testing, ensuring that the sample does not degrade during the waiting period.

What Does a Storage Serum (3) & Plasma (3) Detect?

While the storage process itself does not generate an immediate diagnostic result, the quality control parameters evaluated during the processing phase are critical. The storage protocol assesses and documents the following specimen characteristics to guarantee future diagnostic viability:

• Hemolysis Index: Evaluates the presence of ruptured red blood cells, which can falsely elevate intracellular components like potassium and lactate dehydrogenase in the stored serum or plasma.
• Lipemia Index: Measures the turbidity of the sample caused by high lipid content, ensuring the sample is suitable for future spectrophotometric assays.
• Icterus Index: Documents high bilirubin levels, which can interfere with certain colorimetric laboratory reactions.
• Serum Aliquot Volume: Verifies that each of the three serum cryovials contains the minimum required volume (typically 1.0 to 1.5 mL) for standard diagnostic panels.
• Plasma Aliquot Volume: Confirms that each of the three plasma cryovials contains sufficient volume for coagulation or molecular testing.
• Clotting Completeness: Ensures that the serum sample clotted fully prior to centrifugation to prevent post-centrifugation fibrin clot formation during storage.
• Anticoagulant Integrity: Verifies that the plasma sample was adequately mixed with the anticoagulant to prevent micro-clot formation.
• Sample Barcode Alignment: Confirms that the digital barcode matches the patient's unique identification database across all six vials.
• Storage Temperature Stability: Continuous electronic logging confirms that the samples are maintained at a constant temperature of -80°C (±2°C).
• Aliquoting Sterility: Ensures no bacterial or fungal contamination was introduced during the pipetting process.
• Total Protein Preservation: Serves as a baseline marker for the overall protein concentration within the stored serum.
• Fibrinogen Retention: Confirms that the plasma aliquots retain active clotting factors for future hematological evaluation.
• Electrolyte Stability: Monitors baseline ionic concentrations within the liquid phase of the blood.
• Antibody Viability: Ensures immunoglobulin structures remain intact within the serum aliquots for future serological testing.
• Nucleic Acid Integrity: Preserves circulating cell-free DNA and RNA within the plasma for potential molecular or genetic sequencing.
• Enzymatic Activity: Maintains the functional state of key metabolic enzymes for future kinetic assays.
• Hormonal Stability: Preserves delicate endocrine markers that are highly sensitive to thermal degradation.
• Exogenous Substance Levels: Preserves drug metabolites or toxins for future toxicological or therapeutic evaluations.
• Cryovial Seal Integrity: Confirms that the cryovials are hermetically sealed to prevent evaporation or contamination inside the ultra-low freezer.
• Freeze-Thaw Prevention: Guarantees that the samples have remained completely frozen from the moment of initial storage, preserving molecular structure.

Turnaround Time and Report Access at Chughtai Lab

At Chughtai Lab, the processing, aliquoting, and cryopreservation of the Storage Serum (3) & Plasma (3) samples are completed within hours of the blood draw to ensure maximum analyte stability. Once the samples are successfully secured in the ultra-low temperature freezers, a confirmation report is generated. This report details the successful storage of the six aliquots, their specific storage locations within the biobank, sample quality indicators (such as the absence of hemolysis or lipemia), and the unique barcode numbers assigned to each vial.

Patients and referring physicians can easily access this storage confirmation report online. Chughtai Lab provides a secure online portal and a user-friendly mobile application where reports can be viewed, downloaded, and shared. This digital access ensures that whenever the stored samples need to be retrieved for active diagnostic testing, the physician has all the necessary reference codes and sample quality data readily available.

Storage Serum (3) & Plasma (3) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Hemolysis Index	Non-hemolyzed (Clear, straw-colored liquid)	Hemolyzed (Red-tinged liquid; indicates cell rupture and potential analyte interference)
Lipemia Index	Clear, non-turbid sample	Lipemic (Milky, turbid sample; indicates high lipid levels that may interfere with optical testing)
Icterus Index	Normal bilirubin levels (No yellow-orange discoloration)	Icteric (Deep yellow/orange sample; indicates high bilirubin which can affect chemical assays)
Serum Aliquots (3 Vials)	Three distinct vials, each containing ≥ 1.0 mL of high-quality serum	Insufficient volume in one or more vials; presence of fibrin micro-clots
Plasma Aliquots (3 Vials)	Three distinct vials, each containing ≥ 1.0 mL of fully anticoagulated plasma	Presence of micro-clots due to inadequate anticoagulant mixing; insufficient volume
Storage Temperature	Constant ultra-low temperature of -80°C (±2°C)	Temperature fluctuations above -70°C (compromises long-term analyte stability)
Sample Identification	100% barcode alignment with patient electronic medical record	Mislabeled vials or unreadable barcodes (compromises sample traceability)
Sample Integrity (Post-Centrifugation)	Complete separation of liquid supernatant from cellular components	Incomplete separation; presence of red blood cells or buffy coat in aliquots

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Storage Serum (3) & Plasma (3)?

• Experienced Healthcare Professionals: Chughtai Lab employs highly trained phlebotomists and laboratory technologists specializing in advanced sample processing and biobanking protocols.
• Patient-Focused Care: The lab prioritizes patient comfort and convenience, offering seamless sample collection at numerous centers across Pakistan.
• Quality Diagnostic Services: Operating under strict international quality control standards, Chughtai Lab ensures that every stored sample meets rigorous viability criteria.
• Professional Reporting: Patients receive detailed, transparent storage confirmation reports containing all necessary quality indices and tracking barcodes.
• Modern Diagnostic Approach: Utilizing state-of-the-art ultra-low temperature freezers and automated temperature monitoring, the lab guarantees the highest level of specimen preservation.
• Comfortable Environment: All Chughtai Lab collection centers are designed to provide a clean, safe, and welcoming environment for patients during their visit.
• Convenient Location: With an extensive network of diagnostic centers and home sample collection services throughout Pakistan, accessing professional care is highly convenient.
• Commitment to Accurate Diagnosis: By preserving samples under optimal conditions, Chughtai Lab ensures that future diagnostic tests performed on the stored specimens yield highly accurate and reliable results.